- A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Osteoarthritis and cartilage. 2017 In Process GET IT
- Editorial Comment: Symposium: Sex Differences in Musculoskeletal Disease and Science. Clinical orthopaedics and related research. 2015 Editorial Article GET IT
Times cited: 2
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis and Rheumatism.
Times cited: 565
- Bone loss in rheumatoid arthritis: What role does inflammation play?. The Journal of rheumatology. 1998 Editorial Article GET IT
- Inhibition of interleukin 1 induced chondrocyte protease activity by a corticosteroid and a nonsteroidal antiinflammatory drug. The Journal of rheumatology. 1992 Academic Article GET IT